BioCryst Announces Successful Phase 1 Clinical Trial of BCX7353

By: via Benzinga
BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) today announced that the randomized, placebo-controlled, Phase 1 clinical trial of ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.